News
Public · Published
Raydium's 26% rally cools down below $1.80 — Is downside liquidity calling for RAY?
Raydium's token RAY rose 26% but cooled below $1.80. Injective boosted its outlook, yet Futures selling and stretched conditions may threaten the rally.
Published:
Updated:
What happened
Raydium's token RAY rose 26% but cooled below $1.80. Injective boosted its outlook, yet Futures selling and stretched conditions may threaten the rally.
Confirmed
Global impact / market context
If RAY's rally fails, investors holding it could see losses. Futures selling, which is betting on price drops, adds downward pressure. Stretched conditions mean the price rose too fast, so a pullback becomes more likely.
Analyst inference
This news relates to crypto trading, where prices often swing wildly. Raydium's connection to Injective shows how partnerships can boost sentiment. However, broad market conditions and trader behavior, like Futures selling, can quickly reverse gains.
Analyst inference
What to watch
- Watch RAY's price action: whether it stays below $1.80 or recovers. A sustained drop may signal more downside, while a bounce could mean the rally resumes. Confirmed
- Monitor trading volumes and Futures positions for RAY. High selling volume or increasing short positions, which are bets on price declines, could confirm the threat to the rally. Proposed
- Track Injective's performance and any news about its partnership with Raydium. Positive developments could renew investor interest and support RAY's price, whereas negative news might accelerate the decline. Analyst inference
Affected assets
- RAY — Raydium
- INJ — Injective